Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Pheochromocytoma × Tamoxifen × Clear all

Sponsor

Conditions

Breast Neoplasms 69 Carcinoma, Intraductal, Noninfiltrating 9 Breast Carcinoma In Situ 6 Breast Neoplasms, Male 5 Neoplasms 3 Neoplasm Metastasis 3 Urinary Bladder Neoplasms 2 Inflammatory Breast Neoplasms 2 Sleep Wake Disorders 1 Risk Reduction Behavior 1 Obesity 1 Newly Diagnosed Hormone Positive Clinical Stage 1 or 2 Breast Cancer 1 Mastodynia 1 Glioma 1 Fibrocystic Breast Disease 1 Fibroadenoma 1 Fatigue 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1 Disease Progression 1 Desmoid Tumors 1 Cystic Fibrosis 1 Cystadenocarcinoma, Serous 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Lobular 1 Bulbo-Spinal Atrophy, X-Linked 1 Breast Cancer Metastatic 1 Brain Neoplasms 1 Arthralgia 1 Anatomic Stage IV Breast Cancer AJCC v8 1

Interventions

3-Iodobenzylguanidine 3 cabozantinib 2 tipifarnib 1 pembrolizumab 1 pazopanib 1 lutetium Lu 177 dotatate 1 lenvatinib 1 guadecitabine 1 fostamatinib 1 copper dotatate CU-64 1 atezolizumab 1 Temozolomide 1 Surgical Procedures, Operative 1 Sunitinib 1 Phenoxybenzamine 1 Nivolumab 1 Lutetium-177 1 Lutetium 1 Iodine-131 1 Everolimus 1 Erlotinib Hydrochloride 1 Doxazosin 1 Capecitabine 1 Axitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡